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THE INFLUENCE OF PH ON NUCLEATION, SOLUBILITY AND CRYSTAL
STRUCTURE OF LYSOZYME PROTEIN CRYSTALS
Marc Apgar

ABSTRACT
X-ray diffraction from protein crystals remains the most reliable way to
determine the molecular structure of proteins, and how this structure relates to
biological function. However, we still lack the ability to predict solution conditions
that support the nucleation and growth of high-quality protein crystals for X-ray
diffraction studies. The overall goal of this thesis is two-fold: (a) determine the
nucleation behavior and solubilities for lysozyme crystals with two distinct crystal
structures (orthorhombic vs. tetragonal) and (b) investigate whether these
changes in crystal habit and crystal solubility correlate with any discontinuities in
the liquid-liquid phase boundary of lysozyme that occurs under the same solution
conditions.
We measured lysozyme crystal solubility by nucleating and subsequently
dissolving very small lysozyme crystals in highly supersaturated solutions. The
presence of crystals in our samples is detected and monitored by measuring the
light scattered off the micron-sized crystals. These "turbidity measurements" are
repeated across a range of protein concentrations, for pH 4.6 and 5.6, thereby
vi

yielding the crystal solubility boundary. Changes in crystal structure are assessed
at the end of the experiments by microscopic inspection of the distinct crystal
habits.
Attractive protein interactions in solution also induce liquid-liquid phase
separation. Similar to the crystal solubility measurement, we use the turbidity
increase associated with liquid-liquid phase separation to map out this phase
boundary. Since both crystal formation and liquid-liquid phase separation are
driven by attractive protein interactions, we investigated whether the dramatic
changes in crystal solubility associated with different protein crystal structures
lead to any discernable “discontinuities” in the liquid-liquid phase boundaries.

vii

1. INTRODUCTION
1.1. Motivation
The objective of this thesis is to contribute to our understanding of conditions
that promote or interfere with the nucleation and growth of high-quality protein
crystals from solution. Study of the solution conditions that influence protein
crystal growth leads to further understanding of the nucleation and growth
process. In this study, crystals are nucleated and subsequently dissolved by
respective cooling and warming samples of hen egg white lysozyme. A static
light scattering apparatus is used to detect the presence of crystals or liquid
droplets that form in samples that initially contain lysozyme monomers. The
measurements are repeated across a range of protein concentrations, and for
two separate pH values (pH = 4.6 and 5.6) to obtain phase diagrams. The
specific measurement protocol had to be adjusted to accommodate differences in
the phase nucleation and equilibration behavior of the liquid-liquid phase
boundary, tetragonal crystal solubility, and orthorhombic crystal solubility.

8

1.2. Hen-Egg White Lysozyme: Interaction Forces in Solution

Figure 1 – Three dimensional model of Lysozyme with acid and base residues
indicated with red and green respectively (Source: 2LYZ from pdb.org).

Hen egg white lysozyme is a globular protein with a molecular weight of
14,388 g/mol. Lysozyme is comprised of a single chain of 129 amino acids20
that, because of hydrophobicity, compacts into an ellipsoidal shape
approximately 45Å across1. The net charge of Lysozyme depends on solution
pH and will carry a 10-12 positive charges2 at pH 4.6. It is important to
recognize, however, that proteins are “zwitterionic” by nature, i.e. they will carry a
combination of both positive and negative charges at any given pH. This bipolar
charge distribution gives rise to a permanent dipole moment (and higher charge
distribution moments) that contribute to the attractive protein-protein interactions.

Figure 2 - Illustration of the interaction potentials of Lysozyme at three ranges.
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1.3. Protein Phase Diagrams
Proteins can undergo a variety of phase transitions in solution, including the
formation of crystalline phases and liquid-liquid phase separation, i.e. the
separation of the solution into two liquid phases at vastly different concentrations.
These transitions can occur when the long-range repulsion between the charged
protein molecules is reduced by the presence of salt ions. Negative ions from
dissociated salts attract to a positively charged protein to create an ion cloud with
a net charge that is lower than the protein alone. The electrostatic fields become
screened from neighboring proteins and short-ranged attractive forces become
noticeable.
Molecular dynamics calculations of particles interacting via such short-range
interactions have provided important insights into the expected shape of protein
phase diagrams3. In these models, globular proteins under crystallization
conditions are represented as spherical particles interacting via attractive, short
ranged forces between them5,11. These short range attractions can be
approximated with a Yukawa interaction potential3,

∞(r < σ )

u (r ) =  e δ (σ − r )
− ε r / σ ( r ≥ σ )


(1)

where σ is the diameter of the hard core sphere, while δ and ε characterize
the range and well-depth for the attractive interaction, respectively. The infinite
potential produced when coming in contact with one another (r = σ) is the nature
of hard spheres, and a reasonable assumption for lysozyme3,4. For atoms or
small molecules, Monte Carlo simulation with this interaction potential generate a
phase diagram comparable to typical van-der Waals gases (Figure 3, left
10

panel)22. At low concentrations and high temperatures, the system is in the gas
phase. Upon lowering the temperature, the gas condenses and enters the gasliquid coexistence region (G+L), with the gas-phase and liquid-phase
concentrations in that region given by the left and right branch of the parabolic
coexistence curve. These two branches merge at the critical point (CP). At
higher concentrations, we cross the sublimation phase boundary into the gassolid coexistence region, with the sublimation and gas-liquid coexistence curves
merging at the triple point (TP).

Figure 3 - Schematic temperature-density phase diagrams for hard spheres of
diameter σ with Yukawa attraction of range δ. Left: Standard phase diagram with
a stable G+L coexistence region below the critical point (CP) Right: Phase
diagram for short attraction (δ≤σ/7) which results in G+L coexistence that is
metastable with respect to G+S. (Based on Muschol22)

The shape of this “traditional” phase diagram changes dramatically as the
size of the molecule is increased beyond approximately seven times the range of
the attractive force. Large molecules exhibit a sublimation curve that “hops over”
the G+L coexistence curve (dashed), and results in a metastable phase
boundary below a sublimation curve that is more thermodynamically stable3.
To interpret these results for particles interacting in the gas phase to proteins
suspended in solution, we need to define the gas-phase as protein uniformly
11

dispersed in solution. The gas-liquid coexistence, in turn, represents the
separation of the protein solution into two liquid phases with very different protein
concentration. Proteins will tend to coalesce into dense liquid droplets, as shown
in the liquid-liquid phase separation photograph in Figure 4 below. Crystal
solubility, i.e. the coexistence curves of protein crystals in equilibrium with
proteins dispersed in solution, should be identified with the G+S coexistence
curve (sublimation curve) in the above model. Several investigators have shown
that this simplified model predicts the phase separation boundaries seen with
supersaturated protein solutions4,22,23.

Figure 4 – (A)Liquid-liquid phase separations of bovine γE crystalline in sodium
phosphate for a sample at 22°C for a few minutes. (B)Liquid-liquid phase
separation of thaumatin at -9°C. The initial protein concentration was 229 mg/ml
(source: Asherie5)

1.4. Solubility
Consider a system of solid protein crystals in solution. Protein crystals in a
protein-free solvent will lose protein molecules to the surroundings and will
increase the protein concentration of the solution. Alternatively, a protein-rich
solvent will act as a source of protein molecules that will be consumed during
crystal growth. As long as the crystals don’t entirely melt, the system will reach
an equilibrium concentration at which crystals lose protein molecules at the same
12

rate as they are gained. The concentration of proteins in the solution at
equilibrium is the solubility5.
The van’t Hoff law is a general thermodynamic relationship that can be used
to relate the equilibrium solubility concentration to the solubility temperature.
Suppose a solution containing crystals that is kept at temperature T1 reaches an
equilibrium concentration C1. As the solution temperature is changed to T2 a new
equilibrium is reached at C2. Two equilibrium points are related by the van’t Hoff
expression for solubility6,7:

C
ln  2
 C1


∆H
 = −
R


1 1
 − 
 T2 T1 

(2)

Where ∆H is the enthalpy of crystallization and R is the gas constant. The
relationship can be used to predict all other equilibrium points along the solubility
curve. To plot a solubility curve, C1 and T1 are fixed to a single point and all other
points C2 are calculated by plugging in different temperatures T2. To simplify the
evaluation, equation (2) is rearranged like so:

 ∆H
C 2 = C1 exp
 R

 T2 − T1  

 

T
T
 1 2 

(3)

Assuming T2 is not too far from the reference temperature T1, the
denominator inside the exponential can be approximated as T1T2≈T12 which
allows further simplification,

C 2 = C1 exp(α (T2 − T1 ))

(4)
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where C1 is the solubility concentration at the reference temperature T1 and
the constant α is given by

α=

∆H
RT12

(5)

Figure 5 – van’t Hoff plots for typical values of enthalpy. From equation 4
C1=5.16mg/ml, T1=25°C

Solubility curves are typically two-dimensional graphs that plot concentration
against temperature, with all other conditions held constant. Protein solubilities
can be plotted against temperature8,22, salt concentration22, pH8, or ionic strength
of the buffer9,10. Various experimental conditions can be presented with multiple
plots on a single temperature versus concentration graph. Protein pointmutations can be studied by measuring changes in solubility and some mutations
have been shown to shift or invert the solubility line11.
1.5. Crystal Nucleation and Growth
Crystals will grow at conditions below the solubility curve and will melt at
conditions above. Solutions more concentrated than the solubility are said to be
supersaturated and the degree of supersaturation can be expressed as fractional
difference from Csat. In principle, all supersaturated solutions (C>Csat) should
14

nucleate crystals. In general, nucleation of crystals requires some additional
driving force because there is an energy barrier associated with the surface free
energy for small crystalline clusters12. Protein crystals will hardly ever nucleate
unless concentration exceeds solubility by a factor of least three5 (C>3Csat). Once
protein crystals have nucleated, they will grow at a rate proportional to the square
of supersaturation20, but have been found to not grow at all if supersaturation is
too low (C<2Csat)20. For concentrations in the range 2-3 Csat, crystals grow
readily13,20 and become large enough to be seen with optical microscope in a few
hours. Highly concentrated (>3Csat) solutions grow too quickly and new protein
molecules attach anywhere instead of the energetically favorable sites resulting
in poorly formed crystals with numerous defects14. Extremely high
supersaturation can result in aggregation of protein into amorphous liquid
droplets that lack any long-range order, i.e. liquid-liquid phase separation.
Nucleation is assumed to begin when two monomers bind to create a dimer15.
The second aggregation step will either be binding of an additional monomer to
the dimer of binding of dimer to dimer. Subsequent steps could occur via
additional aggregation pathways because of the increased variety of particle
populations in solution. Some crystal growth has been found to proceed by
addition of higher order aggregates that have preformed in the bulk solution prior
to attachment15. There is some evidence that nucleation begins with low-order
liquid droplets until it reaches a critical size and rearranges into a crystal12.
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2. MATERIALS AND METHODS

2.1. General Approach
Our approach to measure protein phase separation is to take advantage of
the strong temperature dependence of protein solubility and of the dramatic
changes in light scattering intensity associated with phase separation. During
our experiments, we quench the temperature of protein solutions while
measuring changes in light scattering intensity caused by phase separation16,22.

Figure 6 - Illustration showing that scattering increases when
proteins aggregate into larger particles. Left: Diffuse protein (G)
scatters weakly according to Raleigh’s law. Right: Aggregates (L
or S) are larger than incident light wavelength, so that mie
scattering and refraction occurs and scattering increases.

The basic principle of the measurement is readily explained by looking at the
theoretical phase diagram of proteins in solutions (see Figure 7). The starting
point (point 1) of our measurements is the uniform solution phase, equivalent to
the gas phase (G). The sample is then cooled to point 2, which is below the gas16

liquid phase boundary (dashed curve) and two coexisting liquid phases form
(Xs). The phase change can be detected as a rapid increase of light scattering
and confirmed by re-warming the sample above the phase boundary. The
sample is slowly warmed toward point 3 until scattering reduces and the
temperature at which this occurs is recorded.
The temperature is maintained at point 3 until scattering increases again
which is attributed to a phase change into crystals (squares in Figure 7). Protein
crystals can form in the G+S coexistence region, and these crystals will also
contribute to scattering. For crystal solubilities, we had to proceed cautiously
with our measurements since (a) crystal nucleation requires very high values of
supersaturation and (b) crystals, once formed, have to be given long time periods
to equilibrate with their surrounding solutions. Hence temperature changes were
performed in small steps, and subsequent step increases were not taken until the
temperature and scattering intensity during the previous step had stabilized.
Orthorhombic crystals grow and melt slower than tetragonal crystals so these
can be differentiated by the rate of change of scattering intensity. Finally, the
crystals are melted as the sample is slowly warmed from point 3 to point 1, and
the solubility temperature is recorded.
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Figure 7 - Phase diagram with a typical experimental trial shown as a vertical line
and steps shown as numbers. Xs denote liquid-liquid coexistence and squares
denote crystallization.

2.2. Illumination and Detection
To implement these measurements, we modified and improved a
temperature controlled light scattering instrument previously built in our
laboratory17. A schematic overview of the hardware used for the detection of
temperature-induced phase separation in protein solutions is shown in Figure 8.
The light source was a high intensity, AlGaInP light emitting diode
(superbrightleds.com, model RL5-RD1560) which had a center wavelength λ =
638nm, and power output of about 1mW. The LED was powered by a 6 volt DC
battery in series with an R = 330 Ω resistor to deliver an operating voltage of 1.84
V. A power meter measured the light output at P = 1mW and confirmed that it
was stable and noise-free. The light was focused with an f = 15cm lens on the
center of the sample cuvette. Light scattered from the samples was collected
with an f = 30mm lens at a right angle to the incident illumination and was
focused onto a silicon photodiode (UDT sensors, model 11-05-001-1).

18

Figure 8 –Block diagram of the temperature-controlled light scattering instrument
used for determination of lysozyme phase diagram boundaries

The LED, temperature controller and photodiode detector were covered with
a box to prevent ambient room light from entering the photodetector. The photo
current, which is proportional to the incident light intensity, was converted into a
voltage using a high-impedance (R = 100MΩ) current-to-voltage amplifier
(Femto, model DLCPA-200). The amplifier gain was set to 108 and an internal 10
Hz low-pass filter was enabled. The output voltage from the amplifier was
digitized with a data acquisition board (National Instruments, model PCI6221 and
BNC2090 breakout box). Voltage was sampled 100 times per second, and the
average voltage for each one second interval was calculated to create another
filter in software, that was low-pass below 1Hz.
2.3. Temperature Control
The temperature of the protein solutions was controlled by placing the sample
cuvette inside a temperature controller (Quantum Northwest, model TLC50F).
19

The temperature controller has a water-cooled peltier element connected to an
electronic control module that adjusts the current to provide the proper rate of
cooling/heating for a chosen sample temperature. Measurements of the protein
phase separation required that (a) the sample temperature could be changed
under computer control (b) scattering intensities could be acquired and correlated
to actual sample temperatures and (c) sample temperature could be
automatically readjusted in response to changes in light scattering intensity
indicating phase separation. Tap water was run through the peltier cooler for
heat transfer from the controller to maintain temperature of the cuvette holder to
within 0.1° C. A calibrated thermocouple probe was inserted into the top of the
cuvette to measure sample temperature throughout the entire experiment.
These readings were typically 0.1-0.5° C different from the temperature reported
by the controller and lagged behind the set temperature due the thermal
equilibration time required.
The quartz cuvette (Starna, model 9F-Q-10-MS) held 0.8 to 1.7 ml of sample
solution in a rectangular column. It also had a conical cavity at the bottom to
allow a stirring rod to rotate freely. The stirring rod (Fisher 14-512-152) was
actuated with a magnet located at the bottom of the cuvette holder and could be
turned on or off via software. The stirring rod was found to become stuck when
samples became excessively viscous so the drive magnets were upgraded by
the manufacturer early in the experiments. Trials requiring temperatures below
10°C were performed while flushing dry nitrogen gas through the holder to
prevent condensate from forming on the cuvette.

20

Figure 9 – Temperature controlled cuvette holder with water ports indicated

2.4. Preparation of Stock Solutions
All stock solutions were made with deionized water obtained from a fourstage water filtration system (Barnstead E-Pure model D4641). We typically
used two stock solutions for any given trial: a buffer solution adjusted to the
appropriate pH and a buffer/salt solution with salt concentration at twice its final
value. Solutions for measurements were generated by dissolving the protein at
twice its final concentration in the buffer stock solution and mixing it in equal
proportions with the twice-concentrated salt/buffer solution.
To make a 100mM sodium acetate buffer, an appropriate amount of dry
sodium acetate (Fisher cat# BP333-500, purity > 99%) was weighed and
dissolved into water. The pH was adjusted with glacial acetic acid (Fisher cat#
BP1185-500, purity > 99.9%). Solution pH was measured with a calibrated and
temperature compensated pH probe (Fisher model 13-620-185) and pH meter
(Fisher model AR15) until the desired pH was reached. Stocks solutions were
stored in sealed glass bottles that were refrigerated at 5°C.
A stock of buffer with 8% w/v NaCl was prepared by dissolving 80 mg of NaCl
(Fisher cat# BP358-212, purity 99.5%) in 1 ml deionized water and heating it
21

above 80°C to ensure the salt is thoroughly dissociated. Then the solution was
cooled and 100mM of NaAc is added. The pH was set in a similar manner as the
buffer stock. Setting the pH of the salt solution separately ensured that any
effect the salt has on the pH or the pH probe was eliminated.
2.5. Preparation of Measurement Samples
Lyophilized lysozyme protein (Worthington Biochemical, Lakewood, NJ, cat#
LYSF) was weighed out on a scale, gently combined with 1 ml of buffer stock and
warmed to 45°C for at least 15 minutes. Then the solution was filtered through a
0.22 µm syringe filter (Fisher cat# 09-720-3) and transferred to sealed centrifuge
tubes and stored at 45°C prior to the trial.
The actual protein concentration of the sample was measured from the uvabsorption of the sample. A small portion of the sample (typically 10 µl) was
diluted 150-fold into the buffer stock. A spectrophotometer (Thermo Electron,
model UV1) was used to measure the optical absorption of the sample at λ = 280
nm, where the absorption coefficient for lysozyme is known4,22 to be α280 = 2.64
ml/mg cm. Prior to the concentration measurement, the spectrophotometer was
zeroed with a lysozyme-free buffer solution. The absorption measurement was
multiplied by the dilution factor and divided by the absorption coefficient to obtain
the actual lysozyme concentration in mg/ml. The dilution and concentration
measurement was performed at least twice to improve accuracy and to detect
mistakes if and when they occurred.
The accurately measured lysozyme solution was combined, in equal parts,
with the buffer stock containing 8% NaCl to achieve final solution containing half
the measured concentration of lysozyme at 4% NaCl. 400-1000 µl of sample
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was transferred into the quartz measurement cuvette that was placed into the
peltier temperature controller. The sample was allowed to equilibrate to
temperature for several minutes while turning the stirring bar to ensure thorough
mixing of the solution.
The specific sequence chosen for sample preparation was not accidental.
Figure 10 below depicts alternative sample preparation pathways within a typical
protein vs. salt concentration phase diagram. Line A1 (vertical line) represents
adding solid-phase lysozyme directly to a 4% NaCl/buffer solution. Method A1 is
not desirable because the sample will pass through the solid-phase region briefly
which might risk crystal nucleation prior to the onset of measurements. Lines B1
and B2 represent the method employed for these experiments. Note that the
sample is much less likely to cross into the solid-phase region. B1 represents
the 8% NaCl stock solution and B2 represents the lysozyme at twice the final
target concentration.

B2

B1
Figure 10 – Protein Concentration vs. Concentration of NaCl with a typical crystal
solubility region shaded. Arrows indicate pathways for solution preparation.
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2.6. IGOR Software
Automated computer control was achieved with IGOR Pro 5.03 mathematical
software that was purchased from www.wavemetrics.com. Custom written IGOR
routines communicate with the temperature controller, with the data acquisition
card and with the user via a small graphical user interface (GUI). A second-bysecond log was kept for measured scattering intensity, controller temperature
and thermocouple temperature. The program initially determines the scattering
intensity of the homogeneous sample solution while the sample is kept above the
crystal solubility temperature for the given sample composition. This scattering
intensity is considered the minimal scattering intensity, or VClear. The IGOR macro
“start new trial” is invoked to bring up a small GUI window which is used to set
the specific parameters for the trial. Figure 11 below is an image of the GUI at
the beginning of a typical trial.
The settings shown in Figure 11 were for trial 539 which resulted in the data
shown in Figure 14 below. Trial 539 was typical for most trials performed but
specific settings vary from trial to trial. The clouding step is skipped for conditions
where these measurements are not possible, i.e. low protein concentrations. The
crystal growth and the melting steps are usually possible if the cloud point
measurements are possible.
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Figure 11 – Custom-written graphical interface used for controlling the light
scattering experiments

The trial is started by clicking “start” in the GUI and all the steps that the user
has checked are performed sequentially from top to bottom. In this example, the
first step is to preheat the sample for 5-10 minutes at 45°C, while stirring to
ensure that the sample is homogeneous. Then, the stirring rod is turned off and
temperature is lowered to 30°C which is still above the temperature where liquidliquid phase separation is expected to occur. When stabilized, background
intensity, VClear, is measured and recorded as baseline intensity for the remainder
of the trial. The value of VClear will be used as the basis for thresholds in
subsequent steps in the trial.
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Figure 12 - Record of the solution temperature (red) and scattering intensity
(blue) vs time for a lysozyme solution (Clys = 97mg/ml, 4% NaCl, pH = 4.6)
undergoing temperature-induced phase separation. At t =~ 15 min (T = 11°C)
the solution undergoes liquid-liquid phase separation which persists until the
solution is rewarmed to 12.25°C. At t = 60 minutes, the stirring rod is turned on
which immediately induces crystal nucleation. Crystals persisted in solution until
the temperature was raised to 47°C. (Source: trial #330)

2.7. Liquid-Liquid Phase Separation
Liquid-liquid phase separation is induced by stepping the temperature down
until a rapid increase in scattering is detected, which occurred at 15 minutes in
Figure 12 above. The temperature that induced the scattering increase is
recorded as Tcloud. After clouding, TClear is determined by slowly stepping the
temperature back up until the scattering returns close to the baseline intensity,
Vclear.
A photo of a lysozyme solution that has undergone liquid-liquid phase
separation is shown in Figure 13. The separated solution reveals small droplets
of fluid at highly elevated protein concentration observed during the clouded
phase of trial 539, between 40-50 minutes in Figure 14. The droplets are large
relative to wavelength so that incident light undergoes multiple-scattering and
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refraction/reflections at the interfaces of the two solution phases. As a result, the
solution displays a turbid, milky-white color.

Figure 13 – Lysozyme solution after liquid-liquid phase separation. Photo was
taken during the intensity peak at 40 minutes in (Source: trial 488)

2.8. Crystal Nucleation and Solubility Determination
After the sample clears, a constant temperature is maintained while crystals
are allowed to nucleate. The stirrer is turned on because, in previous trials, the
stirrer was found to enhance the crystal nucleation rate. At that point, the
solution is below the expected crystal solubility temperature but above the cloud
temperature for liquid-liquid phase separation (point 3 in Figure 3). Thus, any
dramatic intensity increase can be attributed to the nucleation of many small
crystals. The instrument simply waits at this temperature until there is an
adequate intensity increase, usually 10 times VClear. Next, the temperature is
stepped up slowly while the resulting scattering intensity is monitored. The
temperature is raised until the sample scattering reduces to the background
scattering intensity, indicating that all crystals have melted. This point is
recorded as the solubility temperature TSol.
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Figure 14 - Record of the solution temperature (red) and scattering intensity
(blue) vs time for a lysozyme solution (Clys = 42mg/ml, 4% NaCl, pH = 5.6)
undergoing temperature-induced phase separation. There are three intensity
peaks which correspond (from left to right) to three phases: liquid-liquid phase
separation, tetragonal crystals and orthorhombic crystals. At this concentration,
orthorhombic crystals could not be melted without denaturing lysozyme. (Source:
trial # 539)

2.9. Dilution Used to Measure Solubility at Low Concentrations
For lower protein concentrations, crystal nucleation requires excessively long
time periods. To obtain crystal solubilities at low protein concentrations, crystals
are nucleated at higher lysozyme concentrations, then samples are diluted with
4% NaCl buffer solution and the experiment is resumed. Figure 15 below
illustrates two alternatives for diluting these solutions. The open circle represents
the starting point where high concentration crystals are nucleated and the solid
circle represents the target condition after dilution. Method D1 involves diluting
first and then cooling which is not desirable because the sample will pass outside
the solid-liquid coexistence region and the crystals will melt. Method D2 was
used in these experiments because cooling the sample first ensures that the
crystals do not melt during dilution.
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Note that crystals will grow at the filled circle in the figure but kinetic factors
result in very slow nucleation rates. Growing crystals in these regions was
attempted but abandoned after several hours of waiting for nucleation.

Figure 15 – Two different diluting methods for crystals in solution represented by
two arrows from the open circle to the filled circle. D1 occurs when diluting first
then cooling. D2 occurs when cooling first.

2.10. Freezing Point of a Typical Sample
A typical sample (Clys = 22.2mg/ml, 4%NaCl, pH = 4.6) was used for
determination of the freezing point. The freezing point is important for
establishing a lower measurement limit for the SLS experiments. The sample
was frozen inside the cell until a thermocouple probe was firmly entrenched and
could not be removed. The temperature was slowly increased until the probe was
freed. The probe temperature at this point was -5.4C.
2.11. Denaturing Temperature of Lysozyme
The denaturing temperature of lysozyme was measured by steadily
increasing temperature until scattering increased. The assumption is that the
increased scattering is a result of lysozyme uncoiling and aggregating. Scattering
increased slightly at 63°C and significantly at 65°C as shown in Figure 16 below.
Broide4 obtained similar results and reports that lysozyme irreversibly precipitates
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at 65°C. The denaturing temperature is important because it sets the upper
temperature limit for these experiments.

Figure 16 - Scattering and temperature versus time for 61.4 mg/ml lysozyme in
4% NaCl. Sample denatured at 65°C (trial # 458).

The upper temperature limit results in an upper concentration limit because a
portion of the solubility curve exceeds the denaturing temperature. Denatured
proteins scatter light in a way that cannot be differentiated from light scattered
from crystals. So if crystals do not melt when temperature is raised to ~62°C,
solubility measurement is impossible, as exemplified in Figure 17 below.
Liquid-liquid phase measurements are also difficult at high concentration
because of the tendency of nucleate crystals before the measurement can be
made. The presence of “unmeltable” crystals acts as background scatterering
that cannot be differentiated from liquid droplets, as can be seen in the elevated
intensity at 50 minutes in Figure 17, which occurred before liquid-liquid
separation. When highly-concentrated trials nucleated too many unmeltable
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crystals before liquid-liquid separation, the trial was aborted because no valid
data points could be obtained.

Figure 17 – Record for a concentrated lysozyme solution (Clys=252mg/ml, 4%
NaCl, pH=4.6) that undergoes aggregation early in the trial. Raising the
temperature to 60°C did not reduce scattering which made solubility
determination impossible. (Source: Trial 444)

2.12. Temperature Gradients inside the Sample Cuvette
The vertical temperature gradients inside two types of sample cuvette were
measured by inserting a thermocouple probe into the cuvettes containing water.
The cell holder was set to a constant temperature and allowed to equilibrate
before measuring. An Extech 421305 thermocouple meter was used for these
measurements. Temperature variations in the large cell (Starna 9F-Q-10-MS)
were measured with a small stirring rod at the bottom set to medium speed.
Table 1 – Temperature at four depths inside the Large Starna
cell (9F-Q-10-MS). The top temperature column corresponds to
the set temperature of the controller.

Depth

Temperature (C)

(mm)

45.0

30.0

15.0

5.0

10

44.0

31.2

17.2

7.0
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20

44.4

30.8

16.6

6.3

30

44.6

30.7

16.3

6.1

40

45.0

30.7

15.7

5.8

Table 2 – Temperature at four depths inside the Small Starna
cell (Starna,3-3.45-Q-3) and aluminum carrier. Each column
corresponds to a setting on the temperature controller.

Depth

Temperature (C)

(mm)

45.0

30.0

15.0

5.0

10

44.6

30.1

16.3

6.9

20

45.2

30.5

16.1

6.5

30

45.3

30.5

16.1

6.4

40

45.4

30.5

16.0

6.3

Typical thermocouple probe depth during phase separation experiments was
chosen to be 30 mm; a position close to but slightly above the light beam passing
through the sample.
2.13. Temperature Dependence of the pH for the 100 mM NaAc Buffer
The pH of four batches of stock solutions was measured at four temperatures
to determine whether and how much solution temperature altered buffer pH. The
NaAc buffer was stabilized to 4.6 or 5.6 pH, stored in glass bottles at 5°C for
days-weeks before measurements. A temperature compensated pH probe
(Fisher 13-620-185) was used for all of the pH measurements in this trial. The
first concern when making this type of measurement was to ensure that the pH
changes observed are not simply thermal drift of the pH probe. We used two
NIST traceable buffers with known temperature-dependence (Fisher SB107-500
and SB101-500) to calibrate the probe before measurement at a given
temperature. The instructions that are supplied with the probe say that the
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calibration for elevated pH measurement can be achieved by cycling the probe
from hot and cold samples while monitoring the probe voltage. When the voltage
measured in the cold bath differs by +/- 2mV or less, the probe is claimed to be
calibrated for elevated temperatures. This was performed using two separate
vials of pH=4 buffer standard, at 23°C and 60°C respectively. The
measurements are in Table 3 below.
Table 3 – Output of a pH probe (Fisher 13-620-185) when
measuring identical reference buffers that are maintained at
23°C and 60°C

Measurement

23°C

1

190 mV

2
3

198 mV
188.7 mV

4
5

60°C

198.9 mV
189.4 mV

Notice that the reading at the low temperature deviates less than 2mV. After
completing this calibration, both buffer standards were measured at 60°C. The
standards are labeled to be 4.09 pH and 6.95 pH at these temperatures but the
meter measured 3.81 and 6.98. A pH error of 0.38 was observed after
calibrating the probe with this technique.
We opted for a more conservative calibration technique, by re-calibrating the
probe at the exact temperature where pH measurements were required. To do
this, two vials containing pH standards were placed in a 200 mL water bath.
Four measurement samples were put into the same beaker to ensure
temperature match between calibrations and measurements. The pH probe was
calibrated with the two standards using temperature-specific pH values as
indicated on the label. This calibration was repeated for each temperature prior to
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measuring the four stock solutions. The pH of the stock solutions deviated from
the target pH by at most 0.18 pH units.
Table 4 - pH of four different stock solutions that were used for
many of the trials reported in this work

Stock

A

B

C

D

Target pH

4.5

5.5

5.5

5.5

NaCl %

12

0

8

0

Prep. Date

2/26/07

10/18/07

12/4/07

12/4/07

pH at 60°

4.60

5.60

5.62

5.64

pH at 40°

4.62

5.61

5.60

5.61

pH at 20°

4.53

5.68

5.53

5.66

pH at 10°

4.59

5.55

5.65

5.61

pH at 7°

4.58

5.54

5.59

5.62

6.00

pH

5.50

0% NaCl pH 5.5
8% NaCl pH 5.5
0% NaCl pH 5.5
12% NaCl pH 4.5

5.00
4.50
4.00
0

20

40

60

80

Te mperature (C)
Figure 18 - Temperature dependent pH changes of four buffer/salt solutions
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3. RESULTS AND DISCUSSION
3.1. Enhanced Crystal Nucleation in Response to Solution Agitation

Figure 19 – Portion of a trial record (Clys=78mg/ml, 4% NaCl,
pH=5.5) emphasizing the effect of the stirring rod. Immediately
after stirring starts, crystals nucleate and scattering increases.
(Source: trial 485)

Crystal nucleation is dramatically accelerated when a stirring rod is used to
agitate the solutions. Lysozyme samples at a temperature 1-2°C above the
liquid-liquid coexistence curve would form crystals nearly immediately after
starting the rotation of the stirring rod. One example is shown in Figure 19 above
where light scattering remains low until the stirring rod starts. The scattering can
be attributed to crystal nucleation because of crystals were observed by
microscopic inspection and because scattering reduced when the crystals are
melted by warming. At low protein concentration, crystals would not nucleate
after waiting 2-3 hours without a stirring rod but would nucleate minutes after
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starting the stirring. At extremely low concentrations (< 5 mg/ml), crystals could
not be nucleated with or without a stirring rod. Hence the stirring rod in our
experiments serves two purposes: it prevents the small microcrystals we
nucleate from settling out and we find that it dramatically enhances nucleation
rates.
3.2. Crystal Structure and Habit
Crystal structures are derived from observations of the crystal habits, which
are distinctly different from tetragonal vs. orthorhombic crystals. Crystal habit is
checked by briefly pausing the trial and removing 10 µl of sample from the
cuvette. The removed sample volume is placed onto a microscope slide so that
it can be viewed with an Olympus IX-70 inverted microscope.

Figure 20 -Temperature (red) and scattering intensity (blue) versus time for a
lysozyme solution (Clys = 54mg/ml, 4% NaCl, pH = 5.6) undergoing liquid-liquid
phase separation at 40 minutes, tetragonal crystal growth at 130 minutes and
orthorhombic crystal growth at 220 minutes. (Source: trial #488)

shows one of the earlier trials (Trial 488) performed at pH 5.6. This trial
utilizes a method similar to the preceding trials to grow and then melt the
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tetragonal crystals. At the 200 minute point, the tetragonal crystals are
completely melted and the scattering intensity has returned to the baseline
observed at the beginning of the trial. But after 200 minutes, the scattering
intensity increased again despite a temperature that consistently melted crystals
in previous trials. It is clear that a new crystal type was growing, at a slower rate,
but with a higher solubility temperature. The high solubility temperature appears
to correspond to orthorhombic crystals that grow slower, but are more difficult to
melt. Photos taken at various stopping points throughout the trial reveal
significant changes in crystal appearance as the trial progressed. Before
beginning the trial, the sample was inspected under the microscope and it was
confirmed to be clear of any crystals or aggregates. At several points during the
trial in , aliquots of the sample were photographed and are included in Figure 13,
Figure 21, Figure 22 and Figure 25. The photographs can be compared with
other authors that have associated macroscopic crystal habits with crystal
structure.

Figure 21 – Photo of lysozyme after cycling through the LL phase and stirring for
30 minutes at a temperature slightly above this phase. Note numerous
aggregated crystallites. (Source: Photo 1500, trial #488, 165 minutes)
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Figure 22 – Photo of lysozyme that has been slowly warmed to 42°C taken just
before melting. Note two distinct shapes: squares and prisms that resemble
Figure 23 and Figure 24. (Source: Photo 1511, trial #488, 206 minutes)

Figure 23 – Photo of tetragonal lysozyme crystals from other research. Left:
lysozyme (Clys=100mg/ml, NaCl=4%, 0.1M NaAc, pH=5.0) held at 18.5°C for 3045 minutes. (Source: Gorti18 fig 7) Right: lysozyme (Clys=100-150mg/ml,
NaCl=2.5%,0.05M NaAc, pH=4.6) at 20°C. (Source: Yoshizaki19 fig 4)

Figure 24 – Growth habit of tetragonal lysozyme with indices of axis and faces
20
indicated. (Source: Monaco )
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Figure 25 - Photo of lysozyme (Clys = 54mg/ml, 4% NaCl, pH = 5.6) held at 42°C
for ~30 minutes. Tetragonal crystals melted 18 minutes prior to this photograph.
(Source: Photo 1518, trial #488, 220 minutes)

Figure 26 - Sketch of the crystal photographed in Figure 25

3.3. Crystal Solubility
The solubility measurements are fit to the van’t Hoff equation (equation 4)
with α determined by a least squares fit. The IGOR fitting routines perform best
when fitting to data that lie along a decaying exponential. Before fitting,
temperatures were first multiplied by -1 so that the temperature axis was “flipped”
and a decaying exponential was produced (C vs. -T). The fit was performed and
temperature was again multiplied by -1 before plotting the fits that are shown in
the figures below.
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Figure 27 – Phase diagram of lysozyme (100mM NaAc buffer, 4% NaCl,
pH=4.6). Squares: solubility measurements, Solid line: least squares fit to a van’t
Hoff law (eq. 4), Circles: LL phase measurements plotted for comparison. No
orthorhombic phase was observed at this pH.

Figure 28 - Semi-log plot of Figure 27.

At pH 5.6, both tetragonal and orthorhombic crystals occurred and two
different solubilities were measured and fit to separate curves (Figure 29). The
nucleation rate for orthorhombic crystals increases with increasing protein
concentrations which made measurements of tetragonal solubilities impossible
above 60 mg/ml. As shown in Figure 31 below, tetragonal crystal solubility at pH
5.6 follows almost exactly the same curve as pH 4.6.
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Figure 29 - Phase diagram of lysozyme (0.1M NaAc, pH=5.6, 4% NaCl).
Diamonds: orthorhombic, Squares: tetragonal, Circles: LL phase, Lines: least
squares fits to a van’t Hoff law (eq. 5).

Figure 30 – Semilog plot of Figure 29. Note the two solublities
are equal at approximately 2 mg/ml.
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Figure 31 – Solubility of lysozyme (100mM NaAc, 4% NaCl) tetragonal crystals.
Open squares: pH=4.6, solid squares: pH=5.6, Lines: least squares fits to a van’t
Hoff law (eq. 5).

The solubility data obtained from these experiments suggests that the
notional phase diagram presented in Figure 3 should be modified by adding an
orthorhombic solubility curve as shown in Figure 32. The orthorhombic curve
crosses the tetragonal curve at a point of equivalent solubility (ES) where the
growth of both crystal types reduces free energy equally. At concentrations
above ES, orthorhombic crystals are more energetically favored and more stable
than tetragonal crystals.
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Figure 32 - Phase diagram previously presented in Figure 3 with the
orthorhombic phase added (dotted curve). The orthorhombic phase and
tetragonal phase are equally soluble where the curves cross (ES). ES is at a
concentration lower than the liquid-liquid phase (dashed curve).

To relate the solubility curves to enthalpy of crystal formation, equation 4 can
be solved for ∆H:

∆H = αRT12

(6)

Enthalpy is calculated using the solubility fitting coefficients and are
presented in Table 5 below.
Table 5 - Enthalpies calculated from solubility fitting coefficients
C1
T1
pH NaCl
α
∆H

4.6

4% tetra

5.16

-0.139

298

-24.5 kcal/mol

5.6

4% tetra

4.96

-0.146

298

-25.7 kcal/mol

5.6

4% ortho

2.51

-0.052

298

-9.3 kcal/mol

For comparison to other work in this field, data points were obtained from
Pusey’s24 figure 1, for tetragonal solubility. The Pusey experiments were also
performed with 100 mM Acetate buffer, set to a slightly lower pH = 4.0. The
figure below shows good agreement with data collected in this study.
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Table 6 - Solubility temperatures of tetragonal crystals (0.1M
NaAc, pH = 4.0). (From Pusey24, figure 1)

C (mg/ml)
3
6
9
12

Tsol
17
24
28
30

Figure 33 - Tetragonal solubilities for this work plotted against that of Pusey24

Reported data for orthorhombic crystals are also compared with data
collected here. Orthorhombic solubility reported in this paper is a steep function
of temperature and the crystal enthalpy is 8.5 kcal/mol while data Pusey24 12.6
kcal/mol.
Table 7 - Solubility temperatures of lysozyme (0.1M NaAc,
pH=4.0) orthorhombic crystals (From Pusey, figure 4.)

C (mg/ml)
10
13
15
18
20
23
25
44

Tsol
28
31
36
39
41
43
45

Figure 34 - Solubilities for this work plotted against that of Pusey24

Schall21 used calorimetry to obtain tetragonal phase diagram information for
lysozyme in 50 mM acetate buffer at pH = 4.5. Crystal enthalpies where found
for 3% and 5% NaCl concentrations. Schall reports significantly lower enthalpy
than this work or Pusey24, which might be attributed to the technique or the lower
ionic strength of the buffer.
Table 8 - Solubility compared with what has been found by other
authors. Values from Pusey24 are obtained from fits to reported
data. Values from Schall21 are directly from reported data.

Source pH NaCl

C1

∆H

α

Apgar

4.6

4% tetra

5.16

-0.139

-24.5 kcal/mol

Apgar

5.6

4% tetra

4.96

-0.146

-25.7 kcal/mol

Pusey

4.0

4% tetra

6.73

-0.111

-19.6 kcal/mol

Schall

5.2

3% tetra

-10.5 kcal/mol

Schall

4.6

5% tetra

-17.1 kcal/mol

Apgar

5.6

4% ortho

2.51

-0.052

-9.3 kcal/mol

Pusey

4.0

4% ortho

8.79

-0.052

-9.2 kcal/mol

3.4. Liquid-Liquid Phase Separation
Liquid-liquid phase separation was induced as described in the methods
section above for a range of protein concentrations. The phase boundary plotted
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in Figure 35 resembles a portion of the theoretically predicted coexistence
curve3,23 in Figure 3. Attempts to measure the liquid-liquid (G+L) phase at high
concentrations were hampered by the proclivity to nucleate crystals. The few
data points above 200 mg/ml were successful only because the trials were
performed quickly after sample preparation before the onset of crystals.
Muschol22 reports that the liquid-liquid phase will reach a maxima at a critical
concentration (~255±30 mg/ml), and that this curve follows a mathematical
expression for the bimodal of critical phenomena. It is not possible to fit the data
in this thesis to a mathematical expression because there are insufficient
measurement points near or above the critical concentration.
The liquid-liquid phase measurements at pH 5.6 followed a similar curve,
although it appears translated 5-10 °C higher in temperature (Figure 35). The
trend to shift the coexistence curve upward with increased pH agrees with
simulations23. At pH 5.6, the proclivity for crystal growth was very strong, and it
was not possible to measure the liquid-liquid phase change above 150 mg/ml.

Figure 35 – Liquid-Liquid phase clearing temperatures for lysozyme in 4%NaCl
solution at 4.6 and 5.6 pH
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3.5. Hysteresis in Liquid-Liquid Phase Separation
Using the data recorded by the thermocouple probe, temperature was plotted
against scattering intensity as shown in Figure 36 below. The temperature
required to induce separation (clouding) is several degrees lower than the
temperature for clearing - hysteresis. The same hysteresis can be repeated
when temperature cycles are repeated.

Figure 36 - Intensity plotted against temperature that clearly shows hysteresis of
liquid-liquid phase separation in lysozyme solution (Clys = 42mg/ml, 4% NaCl,
pH = 5.6). The trial began at 30°C and was slowly cooled until it clouded at 8°C.
As the sample was rewarmed, it cleared after temperature rose above 11°C.
(Source: trial #539)

Using the analysis employed by Asherie5, a series of clouding temperatures
are subtracted from the clearing temperatures and are plotted in Figure 37 below.
The temperature difference between Tclear and Tcloud decreases as the solution
concentration approaches the critical concentration5. An exponential fit to these
points is extrapolated to the T=0 axis which can be used to estimate critical
concentration. Using this approach, the critical point(CP in Figure 3) is estimated
to be Ccrit= 219 mg/ml, approximately correct22,24.
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Figure 37 - Temperature difference as measured by thermocouple probe
between clouding and clearing, (4% NaCl, pH = 5.6). The solid line is a best fit:
T=-2.27Ln(C)+12.25 which intersects with the T=0 axis at 219 mg/ml.

48

4. CONCLUSION
The phase diagram of lysozyme can be traced out using a conceptually
straight forward light scattering arrangement. When the data include an
adequate range of concentrations, it is possible to fit the data to the van’t Hoff
expression and fitting parameters yield the enthalpy of crystallization. The
enthalpy of crystallization of tetragonal crystals does not appear to be effected by
pH and the solubility curve is unchanged. However, at pH = 5.6 orthorhombic
crystals can also occur with significantly different solubility and enthalpy.
There were not enough liquid-liquid phase separation data points to perform
a fit to the theoretically expected coexistence curve. At pH=5.6, liquid-liquid
phase separation occurred at higher temperatures which is expected because of
the reduced net charge on Lysozyme. There were no obvious indications that
changes in crystal structure correlate to changes in the coexistence curve for
liquid-liquid phase separation. A discontinuity in the coexistence curve might
occur at the concentration of equivalent solubility (ES in Figure 32) which is too
low in this study to make a determination.
The pronounced effect of the stirring rod on crystal nucleation rates is highly
intriguing. Investigation of this mechanism, however, is beyond the scope of this
thesis.
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